Product Dossier
PRISTIQ
Product Dossier for PRISTIQ (desvenlafaxine, Pfizer). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pfizer
- Active ingredient: desvenlafaxine
- Therapeutic area: Psychiatry
- Related brand: DESFAX
- Related brand: MEDVEN
- Related brand: DESVEN
- Same area: REXULTI
- Same area: NICORETTE
What it is
PRISTIQ is an extended release tablet containing desvenlafaxine (as succinate) available in 50 mg and 100 mg strengths.
PBS listing
PRISTIQ is listed on the PBS in two strengths: 50 mg and 100 mg extended release tablets (as succinate), each with 2 PBS items under restricted supply. The ex-manufacturer price for the 50 mg strength is A$10.64 and for the 100 mg strength is A$12.11.
Regulatory history
PRISTIQ was first listed on the ARTG on 1 June 2010, with both the 50 mg and 100 mg extended release tablet formulations registered on the same date.